Clinical Trials Browser

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Advanced Melanoma

Uveal Melanoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Melanoma, Skin Neoplasms

Melanoma, Neoplasm Metastasis, Skin Neoplasms

Uveal Melanoma

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma

Brain Neoplasms, Melanoma, Neoplasm Metastasis

Melanoma, Neoplasms, Skin Neoplasms

Melanoma, Skin Neoplasms

Uveal Melanoma

Uveal Melanoma, Melanoma

Uveal Melanoma, Melanoma

Brain Neoplasms, Melanoma

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Clinical Trials

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

A Phase II Trial of LM103 in Advanced Melanoma

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

MIZAR-003

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

Ipilimumab + Temozolomide in Metastatic Melanoma

Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma

A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Biochemotherapy With Temozolomide for Metastatic Melanoma

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma

KEYNOTE 002

High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma

A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma

Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection

Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced Melanoma

Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma

Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery

Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome

MEL0107

SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma